Information Sheet

This information sheet  provides a comprehensive overview of tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis that primarily affects the lungs but can involve other parts of the body. It distinguishes between Latent TB Infection (LTBI), which is asymptomatic and non-infectious, and active TB disease, which can be pulmonary (infectious) or extrapulmonary (non-infectious).

This article provides a comprehensive overview of Doxycycline Post-Exposure Prophylaxis (Doxy-PEP), an antibiotic used to reduce the risk of bacterial sexually transmitted infections (STIs) such as chlamydia, gonorrhea, and syphilis following condomless sex. It explains how Doxy-PEP works, the correct dosage and timing (200 mg within 24–72 hours after exposure), and who should or should not take it, including guidance for pregnant individuals. The article discusses potential side effects, interactions with other medications, and considerations regarding antibiotic resistance.

This information sheet outlines how individuals can take a two‑pill (200 mg) dose of doxycycline within 24–72 hours after condomless oral, anal, or vaginal sex to significantly reduce the risk of syphilis, gonorrhea, and chlamydia. It provides clear dosing instructions, timing guidance, and encourages regular STI screening and care coordination.

This information sheet offers an in-depth analysis of current AFP models—including funding mechanisms, stakeholder roles, and implementation strategies—to support sustainability of HIV-related services beyond traditional grant funding. It outlines key considerations and best practices to help health departments and community partners explore and launch innovative financing options for long-term epidemic response planning.

Syphilis remains a persistent sexually transmitted infection that requires rigorous diagnosis and management to prevent transmission, progression, and severe complications. This guideline distilled by Praxis Medical Insights outlines the current consensus from the Centers for Disease Control and Prevention (CDC) and related professional bodies on optimal screening methods, diagnostic interpretations, and treatment regimens.

This information sheet outlines how the Pennsylvania Department of Health improved STI treatment reporting by partnering with REDCap to streamline its PA-NEDSS system. It highlights key steps and considerations for jurisdictions aiming to enhance data quality or implement new reporting programs.

This Maine CDC handout explains Expedited Partner Therapy (EPT) for chlamydia, detailing medication use, precautions, and the importance of abstaining from sex for seven days post-treatment to prevent reinfection.

This information sheet provides essential insights into Hepatitis D, emphasizing its dependence on Hepatitis B for infection. The sheet underscores prevention strategies, notably the protective role of the Hepatitis B vaccine, and highlights the need for awareness among high-risk groups to prevent severe liver complications.

This information sheet provides essential insights into Hepatitis C, detailing its transmission, symptoms, and the importance of early detection. It emphasizes the availability of effective treatments that can cure the infection, highlighting the need for regular testing and awareness to prevent long-term liver complications.

This information sheet highlights key facts about Hepatitis B, including how it spreads, who is at risk, and steps for prevention and treatment. It emphasizes the importance of vaccination, routine testing, and early care to reduce transmission and prevent long-term liver damage.